Biologics facility in Middle East

Project Details

Client
Pharmaceutical company

Location
Middle East

Market
Biologics

Solutions we provided
Design of a greenfield monoclonal antibody production facility

50,000

square meters workshop space

Certified: ISO 9001

Certified 14001

Project Overview

Impressed by KeyPlants’ MBS (Modular Biotech Solutions) design platform, Zist Bio, ZBC, commissioned us to design a greenfield monoclonal antibody production facility in the Middle East.

The 1,900-sqm facility, with a 1,200-sqm processing area, engages in bulk manufacturing as well as aseptic filling with lyophilization to produce a biosimilar, later adding additional oncological monoclonal antibodies.